We have shown previously that different breast cancer cells overexpress both Arf6 and its effector, AMAP1; and that overexpressed Arf6 and AMAP1 then constitute a robust signaling axis to induce invasion and metastasis [11]–[15]. Here, ARF6 is linked to breast carcinoma.